从质母细胞瘤生存20年没有进展的经验中吸取的教训:一个案例报告
1Department of Neurosurgery, HMC Hospital and Advanced Neuro Spine Institute, Ludhiana, Punjab, India.
Neurology India
|May 23, 2025
概括
本案例研究强调了一名质母细胞瘤患者,在彻底切除和照射后,他存活了20多年. 它表明,实现完整的瘤切除可能为一些质母细胞瘤患者提供长期生存.
科学领域:
- 神经瘤学神经瘤学
- 神经外科 神经外科
背景情况:
- 质母细胞瘤 (GBM) 是一种具有攻击性的原发性脑瘤,预后通常不佳,往往导致短生存时间.
- 目前的治疗策略往往优先考虑功能性保存的亚总切除,这可能不是最佳的患者结果.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K


